Search
for
Sort by
Research 301–330 of 1000+
- An Updated in the Management of Alopecia Areata
- Hair Botox: Regain Your Healthy Hair
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Unknown safety profile of ingredients in hair supplements: A call to action for improved patient safety
- Aphalangia possibly linked to unintended use of finasteride during early pregnancy
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Drugs that affect autonomic functions or the extrapyramidal system
- Editorial Note on Next-Generation Therapies and Advance Acne Treatment
- Restolin Hair Supplement: Here are Some Effective Remedies for Hair Fall Control! v1
- Reporting on Adverse Clinical Events
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Finasteride in Androgenic Alopecia
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Contraceptive use in acne
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- A review on Hair Loss & Damage
- Antiandrogens and Androgen Inhibitors
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Pregnancy and Skin
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Appropriate use of metformin in early pregnancy: is there a role for first trimester use?
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Journal of Pigmentary Disorders
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases